COVID-19 (SARS-COV-2 INFECTION)
Clinical trials for COVID-19 (SARS-COV-2 INFECTION) explained in plain language.
Never miss a new study
Get alerted when new COVID-19 (SARS-COV-2 INFECTION) trials appear
Sign up with your email to follow new studies for COVID-19 (SARS-COV-2 INFECTION), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to keep High-Risk COVID patients out of the hospital
Disease control Recruiting nowThis study tests an experimental pill called ibuzatrelvir in adults and teens with COVID-19 who are not hospitalized but have a high risk of becoming severely ill. About 2,330 participants will receive either the pill or a placebo for 5 days, and researchers will track who needs …
Matched conditions: COVID-19 (SARS-COV-2 INFECTION)
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 00:29 UTC
-
VA launches massive study of COVID-19 treatments in 400,000 veterans
Knowledge-focused Recruiting nowThis study looks back at the medical records of up to 400,000 Veterans to see how COVID-19 treatments were used over time and how well they worked. Researchers will also compare treatments for flu and RSV. The goal is to learn which therapies are most effective and for whom, with…
Matched conditions: COVID-19 (SARS-COV-2 INFECTION)
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated May 17, 2026 00:32 UTC
-
Pfizer tests new pill form of COVID drug in healthy people
Knowledge-focused Recruiting nowThis early-stage study tests a new tablet form of the experimental COVID-19 drug ibuzatrelvir in 18 healthy adults. Researchers want to see how much of the drug gets into the blood with the new tablet compared to the original, and whether taking it with food or as a drink changes…
Matched conditions: COVID-19 (SARS-COV-2 INFECTION)
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC